Nife-Par Leman 5 mg/ml, solution buvable

7680697660010 CH-69766 Lösung

No image available

Article details

Package size
30
Selling units
30
Measure
ml
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/08/2026
Patient information leaflet
Français
27/08/2026
Patient information leaflet
Italien
27/08/2026
Summary of Product Characteristics
Allemand
06/03/2026
Summary of Product Characteristics
Français
06/03/2026
Summary of Product Characteristics
Italien
06/03/2026

Detailed composition

Substance Quantity Type Category
nifedipinum
5.0 MG Substance Wirkstoff (Principe actif)
ethanolum 96 per centum
467.0 MG Substance HBESI
glycerolum
- Substance HNIDK
natrii cyclamas
- Substance HNIDK
saccharinum natricum
- Substance HNIDK
E 110
0.2 MG Substance HBESI
aromatica
- Substance AROMA
acidum hydrochloridum
- Substance HNIDK
aqua purificata
- Substance HNIDK
natrium
0.63 MG Substance HBESI

Authorization holder

Leman SKL SA

1213 Lancy

Authorization information

Swissmedic authorization number
69766
Drug name
Nife-Par Leman, solution buvable
Galenic form
LSOR
ATC Code
C08CA05
Authorization status
Z
Dispensing category
B
First authorization
18/12/2025
Authorization expiration date
17/12/2030
IT Number
09.99.0.
Domain
Human medicine

Package details

Description (FR)
NIFE PAR Leman 5 mg/ml sol 5 mg 30 ml
Description (DE)
NIFE PAR Leman 5 mg/ml Lös 5 mg 30 ml
Market launch
01/09/2026
Narcotic (BTM)
No

Available generics (6)

Nifedipin-Mepha 20 retard, Retardtabletten
GTIN: 7680528960104
CHF 14.25
View
Nifedipin-Mepha 20 retard, Retardtabletten
GTIN: 7680528960296
CHF 30.60
View
Nifedipin-Mepha 40 retard, Retardtabletten
GTIN: 7680537530367
CHF 35.15
View
Nifedipin-Mepha 40 retard, Retardtabletten
GTIN: 7680537530374
CHF 69.40
View
Nifedipin Spirig HC 40 CR, Retardtabletten
GTIN: 7680539980733
CHF 28.50
View
Nifedipin Spirig HC 40 CR, Retardtabletten
GTIN: 7680539980740
CHF 50.60
View
Buy us a coffee Explore the data